Table V.
Factors | Recurrence-free survival
|
Cancer-specific survival
|
||||
---|---|---|---|---|---|---|
Univariate
|
Multivariate
|
Univariate
|
Multivariate
|
|||
P-value | HR (95% CI) | P-value | P-value | HR (95% CI) | P-value | |
Age (years) | 0.0246 | 0.0630 | 0.0018 | 0.0327 | ||
≤62 | ||||||
>62 | 1.77 (0.98–3.28) | 3.91 (1.27–17.0) | ||||
Sex | 0.5708 | 0.4909 | ||||
Female | ||||||
Male | ||||||
pT stage | <0.0001 | 0.4095 | <0.0001 | 0.8970 | ||
≤pT2 | ||||||
≥pT3 | 1.41 (0.63–3.26) | 1.09 (0.32–4.33) | ||||
ISUP grade | <0.0001 | 0.8596 | <0.0001 | 0.0355 | ||
1/2 | ||||||
3/4 | 1.07 (0.53–2.19) | 9.31 (1.73–172) | ||||
TN | <0.0001 | <0.0001 | <0.0001 | 0.0003 | ||
Absence | ||||||
Presence | 8.01 (3.91–16.5) | 8.56 (2.80–29.9) | ||||
MVI | <0.0001 | 0.0057 | <0.0001 | 0.2185 | ||
Absence | ||||||
Presence | 2.97 (1.33–6.30) | 2.32 (0.56–8.67) |
ccRCC, clear cell renal cell carcinoma; ISUP, International Society of Urological Pathology; TN, tumor necrosis; MVI, microvascular invasion; HR, hazard ratio; CI, confidence interval.